International Stem Cell Corporation

International Stem Cell Corporationverified

ISCO

Price:

$0.14

Market Cap:

$1.12M

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cell...[Read more]

Industry

Biotechnology

IPO Date

2007-05-01

Stock Exchange

OTC

Ticker

ISCO

The Enterprise Value as of December 2025 (TTM) for International Stem Cell Corporation (ISCO) is 640.61K

According to International Stem Cell Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 640.61K. This represents a change of -77.97% compared to the average of 2.91M of the last 4 quarters.

International Stem Cell Corporation (ISCO) Historical Enterprise Value (quarterly & annually)

How has ISCO Enterprise Value performed in the past?

The mean historical Enterprise Value of International Stem Cell Corporation over the last ten years is 6.20M. The current 640.61K Enterprise Value has changed 932.74% with respect to the historical average. Over the past ten years (40 quarters), ISCO's Enterprise Value was at its highest in in the December 2018 quarter at 11.46M. The Enterprise Value was at its lowest in in the September 2025 quarter at 560.57K.

Quarterly (TTM)
Annual

Average

6.20M

Median

6.39M

Minimum

3.09M

Maximum

10.74M

International Stem Cell Corporation (ISCO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of International Stem Cell Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 100.93%

Maximum Annual Enterprise Value = 10.74M

Minimum Annual Increase = -65.38%

Minimum Annual Enterprise Value = 3.09M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20243.26M5.65%
20233.09M-37.95%
20224.97M-34.41%
20217.58M18.03%
20206.42M-12.34%
20197.33M-31.79%
201810.74M69.27%
20176.35M100.93%
20163.16M-65.38%
20159.13M-25.21%

International Stem Cell Corporation (ISCO) Average Enterprise Value

How has ISCO Enterprise Value performed in the past?

The current Enterprise Value of International Stem Cell Corporation (ISCO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.77M

5-year avg

5.07M

10-year avg

6.20M

International Stem Cell Corporation (ISCO) Enterprise Value vs. Peers

How is ISCO’s Enterprise Value compared to its peers?

International Stem Cell Corporation’s Enterprise Value is greater than Biocure Technology Inc. (526.57K), less than Evofem Biosciences, Inc. (66.34M), less than Chia Tai Enterprises International Limited (253.64M), less than Marizyme, Inc. (26.63M), less than Biomind Labs Inc. (1.87M), less than Biora Therapeutics, Inc. (37.44M), less than NovelStem International Corp. (2.69M), less than Unity Biotechnology, Inc. (0), greater than DATATRAK International, Inc. (10.00K), less than Vaccinex, Inc. (791.65K),

Build a custom stock screener for International Stem Cell Corporation (ISCO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like International Stem Cell Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

International Stem Cell Corporation (ISCO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like International Stem Cell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is International Stem Cell Corporation's Enterprise Value?

What is the highest Enterprise Value for International Stem Cell Corporation (ISCO)?

What is the 3-year average Enterprise Value for International Stem Cell Corporation (ISCO)?

What is the 5-year average Enterprise Value for International Stem Cell Corporation (ISCO)?

How does the current Enterprise Value for International Stem Cell Corporation (ISCO) compare to its historical average?